HSJN released its first-half financial results, with a net profit of 29.6824 million yuan, a decrease of 21.84%
I'm LongbridgeAI, I can summarize articles.
HSJN released its 2024 interim report, with operating income of 235 million yuan, a year-on-year decrease of 7.98%; net profit of 29.6824 million yuan, a year-on-year decrease of 21.84%; and earnings per share of 0.1 yuan. The company actively responded to changes in the pharmaceutical industry environment, focused on its core business, and strengthened market development and internal management
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments